Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Endothelial cell activation during edematous attacks of hereditary angioedema types I and II.

Kajdácsi E, Jani PK, Csuka D, Varga LÁ, Prohászka Z, Farkas H, Cervenak L.

J Allergy Clin Immunol. 2014 Jun;133(6):1686-91. doi: 10.1016/j.jaci.2013.12.1072. Epub 2014 Feb 9.

PMID:
24522092
2.

Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.

Kajdácsi E, Jani PK, Csuka D, Varga L, Prohászka Z, Farkas H, Cervenak L.

J Clin Immunol. 2016 Feb;36(2):160-70. doi: 10.1007/s10875-016-0239-8. Epub 2016 Feb 12.

PMID:
26873707
3.

Endothelial cell function in patients with hereditary angioedema: elevated soluble E-selectin level during inter-attack periods.

Czúcz J, Schaffer G, Csuka D, Walentin S, Kunde J, Prohászka Z, Farkas H, Cervenak L.

J Clin Immunol. 2012 Feb;32(1):61-9. doi: 10.1007/s10875-011-9606-7. Epub 2011 Oct 19.

PMID:
22009003
4.

Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management.

Bork K, Davis-Lorton M.

Eur Ann Allergy Clin Immunol. 2013 Feb;45(1):7-16. Review.

PMID:
23678554
5.

High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.

Suffritti C, Zanichelli A, Maggioni L, Bonanni E, Cugno M, Cicardi M.

Clin Exp Allergy. 2014 Dec;44(12):1503-14. doi: 10.1111/cea.12293.

PMID:
24552232
6.

Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency.

Bork K, Hardt J, Witzke G.

J Allergy Clin Immunol. 2012 Sep;130(3):692-7. doi: 10.1016/j.jaci.2012.05.055. Epub 2012 Jul 28.

PMID:
22841766
7.

Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency.

Farkas H, Csuka D, Veszeli N, Zotter Z, Szabó E, Varga L.

Allergy Asthma Proc. 2014 May-Jun;35(3):255-9. doi: 10.2500/aap.2014.35.3743.

PMID:
24801469
8.

Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.

Farkas H, Csuka D, Gács J, Czaller I, Zotter Z, Füst G, Varga L, Gergely P.

Clin Immunol. 2011 Oct;141(1):58-66. doi: 10.1016/j.clim.2011.05.004. Epub 2011 May 19.

PMID:
21636327
9.

The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency.

Csuka D, Munthe-Fog L, Skjoedt MO, Kocsis A, Zotter Z, Gál P, Varga L, Farkas H, Füst G, Garred P.

Mol Immunol. 2013 Jul;54(3-4):271-7. doi: 10.1016/j.molimm.2012.12.015. Epub 2013 Jan 12.

PMID:
23318225
10.

Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema.

Loffredo S, Bova M, Suffritti C, Borriello F, Zanichelli A, Petraroli A, Varricchi G, Triggiani M, Cicardi M, Marone G.

Allergy. 2016 Jul;71(7):989-96. doi: 10.1111/all.12862. Epub 2016 Mar 17.

PMID:
26873113
11.

Activation of the ficolin-lectin pathway during attacks of hereditary angioedema.

Csuka D, Munthe-Fog L, Hein E, Zotter Z, Prohászka Z, Farkas H, Varga L, Garred P.

J Allergy Clin Immunol. 2014 Dec;134(6):1388-1393.e1. doi: 10.1016/j.jaci.2014.05.030. Epub 2014 Jul 16.

PMID:
25042985
12.

Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.

Kaplan AP, Joseph K.

Adv Immunol. 2014;121:41-89. doi: 10.1016/B978-0-12-800100-4.00002-7. Review.

PMID:
24388213
13.

Clinical Pattern and Acute and Long-term Management of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency.

Gómez-Traseira C, Pérez-Fernández E, López-Serrano MC, García-Ara MC, Pedrosa M, López-Trascasa M, Caballero T.

J Investig Allergol Clin Immunol. 2015;25(5):358-64.

14.

Diagnosis and treatment of hereditary angioedema.

Canonica GW, Rossi O.

Panminerva Med. 2012 Sep;54(3):241-53. Review.

PMID:
22801442
15.

C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.

Varga L, Széplaki G, Visy B, Füst G, Harmat G, Miklós K, Németh J, Cervenak L, Karádi I, Farkas H.

Mol Immunol. 2007 Feb;44(6):1454-60. Epub 2006 Jun 5.

PMID:
16750855
16.

A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes.

Joseph K, Bains S, Tholanikunnel BG, Bygum A, Aabom A, Koch C, Farkas H, Varga L, Ghebrehiwet B, Kaplan AP.

Allergy. 2015 Jan;70(1):115-9. doi: 10.1111/all.12520. Epub 2014 Oct 15.

PMID:
25186184
17.

Management of dental-oral procedures in patients with hereditary angioedema due to C1 inhibitor deficiency.

Jurado-Palomo J, Muñoz-Caro JM, López-Serrano MC, Prior N, Cabañas R, Pedrosa M, Burgueño M, Caballero T.

J Investig Allergol Clin Immunol. 2013;23(1):1-6.

18.

Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency.

Cugno M, Zanichelli A, Bellatorre AG, Griffini S, Cicardi M.

Allergy. 2009 Feb;64(2):254-7. doi: 10.1111/j.1398-9995.2008.01859.x. Epub 2008 Dec 4.

19.

Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.

Farkas H, Jakab L, Temesszentandrási G, Visy B, Harmat G, Füst G, Széplaki G, Fekete B, Karádi I, Varga L.

J Allergy Clin Immunol. 2007 Oct;120(4):941-7. Epub 2007 Aug 29.

PMID:
17761272
20.

A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).

Bork K.

Clin Rev Allergy Immunol. 2016 Oct;51(2):183-92. doi: 10.1007/s12016-016-8544-9. Review.

PMID:
27207174
Items per page

Supplemental Content

Write to the Help Desk